Go offline with the Player FM app!
Developing Accessible Monoclonal Antibodies to Treat COVID-19 with Vu Truong Aridis Pharmaceuticals TRANSCRIPT
Manage episode 287434618 series 99915
Vu Truong, CEO, Aridis Pharmaceuticals is taking on the challenge of making an inhaled monoclonal antibody to treat COVID-19 to allow for the easier patient access. Drawing on their work in infectious diseases and with a number of monoclonal antibodies candidates to treat bacteria infection associated with superbugs and antibiotic resistance, Aridis is finding ways to overcome lack of usage of similar potent antibodies from Regeneron and Eli Lilly to combat the coronavirus.
@Aridis_Pharma #AridisPharma #Aridis #Superbugs #AMR #InfectiousDisease #COVID19 #mAb #MonoclonalAntibody #immunotherapy #RespiratoryInfections #CoronavirusVariants
1731 episodes
Manage episode 287434618 series 99915
Vu Truong, CEO, Aridis Pharmaceuticals is taking on the challenge of making an inhaled monoclonal antibody to treat COVID-19 to allow for the easier patient access. Drawing on their work in infectious diseases and with a number of monoclonal antibodies candidates to treat bacteria infection associated with superbugs and antibiotic resistance, Aridis is finding ways to overcome lack of usage of similar potent antibodies from Regeneron and Eli Lilly to combat the coronavirus.
@Aridis_Pharma #AridisPharma #Aridis #Superbugs #AMR #InfectiousDisease #COVID19 #mAb #MonoclonalAntibody #immunotherapy #RespiratoryInfections #CoronavirusVariants
1731 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.